Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
"If the Nifty falls below the 10,680 mark, it could correct to 10,500 levels on the back of further selling," says Shitij Gandhi of SMC Global Securities
"In Nifty options, maximum open interest for puts is seen at 10,700 followed by 10,600 which is likely to act as crucial support for the market. In calls, 11,000 strike has seen maximum OI," says Ashish Chaturmohta of Sanctum Wealth Management
In terms of returns, the BSE Midcap and Smallcap indices saw a cut of 11 percent and over 14 percent so far in 2018, compared to an over 1 percent return in the Sensex.
Buy Godrej Consumer Products, says Rajesh Palviya Rajesh Palviya Godrej CP has given the breakout from its last five weeks consolidation range of Rs 1,150-1,070 on the weekly closing basis. This breakout is accompanied with high volumes indicating increased participation. The stock is forming higher top higher bottom formation on daily/weekly charts indicates sustained uptrend. The strength indicators are in positive territory which indicates positive momentum to continue further. Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
The stock is currently trading above all its crucial SMA i.e. 20, 50, 100.
Investors are advised to remain cautious and watch out for two levels: 10,770 on the upside and 10,550 on the down.
For the week, Axis Securities expects the index to trade in a 10,550-10,820 range.
The market's upward trajectory was in spite of volatility in stocks traded abroad and crude hitting multi-year highs, primarily because investors continued to be hopeful that earnings would keep getting better.
IIFL has published a report on pharmaceutical companies and it specifically analyses US business margins. In an interview to CNBC_TV18, Abhishek Sharma, Vice President and Pharma Analyst at IIFL spoke about the latest happenings in the sector.
After the recent correction, valuations of Indian market have come down to a reasonable level which should give motivation to investors to accumulate quality stocks on declines.
Ashwani Gujral of ashwanigujral.com recommends buying Blue Star, Sun Pharma and LIC Housing Finance.
Sandeep Wagle of powermywealth.com is of the view that one can buy NIIT Tech and sell Torrent Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Firstsource Solutions and Future Lifestyle and can sell Dish TV.
Mitessh Thakkar of miteshthacker.com suggests buying Amara Raja Batteries and Cholamandalam Investment.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Adani Enterprises, Tata Elxsi, Reliance Capital and Torrent Pharma and can sell Yes Bank and KPIT Tech.
CLSA has retained its Underperform rating on Cadila with reduced target price at Rs 440 from Rs 480 per share earlier following cut in FY19-20 margin estimate by 100 bps & earnings by 5-7 percent.
Sudarshan Sukhani of s2analytics.com suggests buying Dabur India, Vedanta and Torrent Pharma.
The positive takeaway for the BJP is that it will form the government for the fifth term in a row despite winning the elections by a small margin. But, there are certain stocks which have always given multibagger returns of up to 4000 percent whenever BJP won in Gujarat since 2002.
Mitessh Thakkar of mitesshthakkar.com is of the view that one may buy Torrent Pharma.
The global investment bank analysed the portfolios of 90 percent (by value) of the domestic equity funds to assess the impact.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Cipla, Hero MotoCorp and Raymond while he is bullish on Ashok Leyland and advises selling Torrent Pharma.
The pharma companies have posted mix earnings in the quarter ended September 2017 on the back pricing pressure and increased competition.
Torrent Pharmaceuticals will acquire Unichem Laboratories' branded formulation business in India and Nepal for Rs 3,600 crore.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Repco Home Finance and buy Gujarat State Fertilizers & Chemicals, Dr Reddy’s Laboratories and Sun TV Network.
Godrej Properties, Torrent Pharma, Hindalco and Titan, among others, on the radar of investors on Monday.